Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
PFI Outlines Three-Ecosystem Strategy for Long-Term Global Growth
Wyndham Caps Record First Half in Asia-Pacific
Zeus Wallet taken offline after cyberattack, says no customer funds at risk
5 Best AI Notetakers (2026), Tested and Reviewed
Côtes Catalanes: the wine with the renegade spirit
Meteor Showers, Eclipses, and More Are on the August 2026 Astronomical Calendar
Crypto wrench attacks steal more than $30M so far in 2026: Chainalysis
Nadia Sawalha threatens ITV with legal action over Loose Women removal
Emmerdale actor Lawrence Robb joins Strictly line-up
PFI Shares International Expansion and Capital Development Roadmap
PFI Introduces Its Stablecoin Aggregator Ecosystem
Russia targets Maga influencers ahead of German state vote
PFI Introduces Its Open Liquidity Network for Cross-Border Finance
Kevin Warsh to stick with lean Fed messaging despite market backlash
Listing Financial Audit Fully Approved, Withdrawal Channel to Fully Open on August 7
Henkel Raises Sales Guidance for 2026
EBay Gives Solid Outlook, Says It Paid More to Acquire Depop
Comprehensive Telecommunication Solutions by FPT: Fast Internet and Quality Entertainment
Flying more sustainably with “shark skin”
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute